AddLife AB engages in the ownership and acquisition of firms in niche segments under the healthcare sector. The company is headquartered in Stockholm, Stockholm and currently employs 2,295 full-time employees. The company went IPO on 2015-03-16. The firm markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The firm operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The firm operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.
根據最新的財務報表(Form-10K),Tracker Corporation of America 的總資產為 $0,淨isProfitable}為 $0
ADDLF 的關鍵財務比率是什麼?
Tracker Corporation of America 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
AddLife AB (publ) 的收入按細分市場或地理位置如何劃分?
Tracker Corporation of America 最大收入來源為 Electrical Energy,在最近的收益報告中收入為 13,044,455,000,000。就地區而言,Brazil 是 Tracker Corporation of America 的主要市場,收入為 6,860,996,000,000。
AddLife AB (publ) 是否盈利?
無,根據最新的財務報表,Tracker Corporation of America 的淨損失為 $0